| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |